CA2502965A1 — Dosage form that is safeguarded from abuse
Assigned to Gruenenthal GmbH · Expires 2004-05-06 · 22y expired
What this patent protects
The invention relates to a dosage form that is safeguarded from abuse. In addition to one or more active substances that could be subject to abuse, sa id form comprises two or more of the following constituents (a)-(d): (a) at lea st one substance that irritates the nasal and/or …
USPTO Abstract
The invention relates to a dosage form that is safeguarded from abuse. In addition to one or more active substances that could be subject to abuse, sa id form comprises two or more of the following constituents (a)-(d): (a) at lea st one substance that irritates the nasal and/or pharyngeal region; (b) at leas t one agent that increases viscosity, which forms a gel in an extract that is obtained from the dosage form with the aid of a required minimum quantity of an aqueous liquid, whereby the gel can still be visibly differentiated after being introduced into an additional quantity of an aqueous liquid, (c) at least one antagonist for the active substance or substances that could be subject to abuse, (d) at least one emetic.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.